Location History:
- Tsukuba, JP (1998)
- Ibaraki, JP (2000 - 2011)
Company Filing History:
5 out of 237 
2 out of 273 
1 out of 2,405 
Years Active: 1998-2011
Title: Ken-ichi Tanaka: A Pioneer in G Protein-Coupled Receptor Research
Introduction
Ken-ichi Tanaka is an accomplished inventor based in Ibaraki, Japan, known for his significant contributions to the field of biochemistry and pharmacology. With a total of eight patents to his name, he has played a pivotal role in advancing the understanding of guanosine triphosphate (GTP)-binding protein-coupled receptors, which are crucial in cellular signaling processes.
Latest Patents
Among his latest innovations, Tanaka has developed the guanosine triphosphate (GTP)-binding protein-coupled receptor protein known as BG37. His research involved conducting a similarity search of the amino acid sequence of known G protein-coupled receptor proteins in GenBank. This work led to the identification of a novel human GPCR gene named 'BG37', where he successfully cloned cDNA containing the open reading frame (ORF) of this gene and determined its nucleotide sequence. Additionally, Tanaka isolated the novel GPCR 'BG37' genes from mouse and rat specimens. The innovative applications of the BG37 receptor include enabling the screening of ligands and compounds that inhibit ligand binding, thus identifying candidate pharmaceutical compounds that can regulate signal transduction from the BG37 receptor.
Career Highlights
Throughout his career, Ken-ichi Tanaka has collaborated with leading companies in the pharmaceutical field, including Banyu Pharmaceutical Co. Ltd. and Toagosei Company, Ltd. His work has been instrumental in bridging the gap between molecular biology and drug development, demonstrating his considerable impact on the biopharmaceutical industry.
Collaborations
Tanaka’s research endeavors have led to fruitful collaborations with notable colleagues such as Takao Nakamura and Hiraku Itadani. These partnerships have fostered a dynamic research environment, enabling the exploration of innovative approaches in GPCR research and pharmaceutical applications.
Conclusion
Ken-ichi Tanaka's innovative work and his eight patents reflect his dedication to advancing scientific knowledge in the realm of G protein-coupled receptors. His contributions not only enhance our understanding of cellular signaling but also pave the way for the development of new pharmaceuticals that could significantly improve health outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.